Nicholas O’Donoghue

Nicholas O’Donoghue focuses on how regulation, workforce pressures and public expectations shape the business of community pharmacy. He writes for the Australian Journal of Pharmacy, producing news, analysis and longer reads on pharmacy practice, remuneration and the relationship between pharmacies, regulators and government. With more than a decade of experience on regional, national and specialist publications in Australia, he brings a business-minded lens that stays close to frontline pharmacy operations.

Regulation, enforcement and business risk

O’Donoghue regularly reports on regulatory enforcement and the commercial risks it creates for pharmacies and medicine suppliers. He covers clampdowns on illicit vaping, including Therapeutic Goods Administration raids that seized $1.8 million worth of illegal vapes from Sydney suppliers. His reporting follows how authorities pursue non‑compliant operators, frame these actions as public health measures, and disrupt informal or grey-market channels.

He also examines structural policy moves that reshape service delivery, such as union-backed plans for public hospital pharmacy services to be brought under the management of South Australia Pharmacy. In this kind of piece he tracks how industrial relations, government decisions and service insourcing change responsibilities and funding flows. Alongside this, he reports on the risks posed by peptide use to both patient health and sports integrity, reflecting an interest in the overlap between performance enhancement markets, regulation and professional ethics. Across these stories, he treats enforcement and integrity issues as business conditions that pharmacies and related operators must navigate.

Workforce, pay and scope of practice

A significant part of O’Donoghue’s work follows the pharmacy workforce, from pay rates to registration numbers and role expansion. He writes on award wage movements, such as the rise in pharmacy award rates to keep up with inflation, detailing how pay adjustments affect owners and employees across the sector. He reports on survey findings that suggest federal government decisions are leaving pharmacists out of pocket, using data to show how policy settings translate into financial pressure on community pharmacy businesses.

His longer reads explore workforce capacity and availability, including analysis noting that pharmacist registration numbers are near record levels while shortages persist across the country. In these pieces he looks at the mismatch between headcount and on‑the‑ground staffing, and what that means for service levels and business sustainability. He also covers debates over scope of practice, reporting that most pharmacists believe expanding their scope is “necessary” for the profession’s future, and presenting scope expansion as both a professional aspiration and a strategic business issue. Taken together, his coverage links employment conditions, workforce planning and role definition to the viability and evolution of pharmacy businesses.

Community pressures, patient impact and service innovation

O’Donoghue’s news reporting often centres on the pressures community pharmacies face and how these pressures affect patients. He writes on medicine shortages from the patient perspective, including stories in which patients report that support is lacking when shortages occur. He covers pharmacies being targeted by anti‑vaxxers, detailing guidance issued to pharmacists on how to respond when confronted by harassment and highlighting the reputational and safety challenges that can arise at the pharmacy counter.

He follows the experiences of individual proprietors, such as an owner seeking health minister support to reopen and relocate a pharmacy, showing how bureaucratic decisions and political advocacy intersect with local business continuity. His reporting also tracks service innovations and sustainability initiatives, including coverage of TerryWhite Chemmart joining an injection pen recycling pilot aimed at keeping medical injection pens out of landfill. In the Pharmacy Matters series, he reports on measures like free naloxone vending machines being rolled out across Victoria as an additional pathway for overdose prevention, reflecting interest in harm minimisation models that sit alongside traditional dispensing. He covers professional gatherings such as the APP conference, where speakers urge pharmacists to “shake off” attacks, capturing how leaders frame resilience and public criticism within the profession. Across these stories he presents pharmacies as both businesses and community touchpoints, under strain but experimenting with new services and support structures.

Pharmacy history and professional identity

Beyond contemporary news, O’Donoghue contributes extensively to AJP’s Pharmacy History coverage, exploring how past controversies and regulations helped define the profession. He revisits cases such as a chemist fined for the sale of medicated wine, using historical incidents to show earlier boundaries around pharmacy practice and commercial behaviour. He writes about untrained individuals managing apothecaries and tales of poisonings that captured headlines in early editions of the journal, illustrating how questions of training, competence and public safety have long been central to pharmacy.

In his piece on the “rehabilitation of pharmacy,” set in February 1936, he reports on contemporary calls for “revolution, not rehabilitation” in community pharmacy, documenting an earlier era’s push for structural change and professional renewal. These historical reads sit alongside his modern business and policy reporting, building a sense of continuity between the sector’s formative debates and its current struggles over scope, remuneration and public trust. The combination of archival exploration and present‑day analysis gives his coverage a depth that is unusual for a business‑focused beat in a specialist health publication.